Pharmacy Benefit Managers: The Middlemen of Medicare

Grace Morgan

April 29, 2019

TPA joined together with free-market groups voicing strong support for the Trump Administration’s efforts to eliminate drug rebate programs. While most actors in the drug pricing debates are held accountable, for too long PBMs have been able to remain unchallenged. President Trump is proposing to end this era of backdoor deals in the drug industry, bring real transparency to drug markets, and deliver savings directly to patients when they walk into the pharmacy.